RE:RE:RE:Roche to acquire Carmot Therapeutics. Can't comment on any important relationships the board or management has developed. However, upon re reading the biography's of the Board, it appears that their careers have been immersed in the development of biotechnology and life sciences. Based solely on credentials it would appear these folks should be capable of producing a market strategy that promotes shareholder desires. At the very least, they have been educated in either the business end or medical or both. Their working knowledge in the field of biosciences should enable them to work together synergistically to produce. Many many boards of directors come from all different industries etc. The important question is ....are they involved enough, do they meet/talk enough or are they acting in their own interests and just enjoy another credential attached to the resume.